• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NQO1基因C609T多态性与前列腺癌风险之间的关联。

Association between NQO1 C609T polymorphism and prostate cancer risk.

作者信息

Sun Zihan, Cui Yuling, Pei Jing, Fan Zhiqiang

机构信息

Department of Laboratory Diagnosis, General Hospital of Jinan Military Region, 25 Shifan Road, Tianqiao District, Jinan, 250031, Shandong, China.

出版信息

Tumour Biol. 2014 Aug;35(8):7993-8. doi: 10.1007/s13277-014-2051-5. Epub 2014 May 17.

DOI:10.1007/s13277-014-2051-5
PMID:24838947
Abstract

Published studies on the association between NQO1 C609T polymorphism and prostate cancer risk have yielded conflicting results. Thus, a systemic review and meta-analysis of published studies were performed to assess the possible association. All eligible studies of NQO1 C609T polymorphism and prostate cancer risk were collected from the PubMed and the Cochrane Library. Statistical analyses were performed by Review Manage 5.0 and Stata 11.0. A total of 6 available studies were considered in the present meta-analysis, with 717 cases and 1,794 controls. When all groups were pooled, there was no evidence that NQO1 C609T had significant association with prostate cancer under additive, recessive, dominant, and allelic models. When stratifying for the race, our analysis suggested that NQO1 C609T was associated with prostate cancer risk in Asians when using dominant (TT + CT vs CC: OR = 1.419, 95 % CI = 1.053 - 1.913, P = 0.021) and allelic models (OR = 1.337, 95 % CI = 1.014 - 1.763, P = 0.040) to analyze the data. However, no significant associations were found in Caucasians. This meta-analysis suggested that NQO1 C609T polymorphism most likely contributes to increased susceptibility to prostate cancer in the Asians. Further large-scale and well-designed case-control studies are necessary to validate the risk identified in the present meta-analysis.

摘要

关于NQO1基因C609T多态性与前列腺癌风险之间关联的已发表研究结果相互矛盾。因此,我们进行了一项已发表研究的系统评价和荟萃分析,以评估可能存在的关联。我们从PubMed和Cochrane图书馆收集了所有关于NQO1基因C609T多态性与前列腺癌风险的符合条件的研究。使用Review Manage 5.0和Stata 11.0进行统计分析。本荟萃分析共纳入6项可用研究,包括717例病例和1794例对照。当合并所有组时,没有证据表明在加性、隐性、显性和等位基因模型下,NQO1基因C609T与前列腺癌存在显著关联。在按种族分层时,我们的分析表明,在亚洲人中,使用显性模型(TT + CT vs CC:OR = 1.419,95%CI = 1.053 - 1.913,P = 0.021)和等位基因模型(OR = 1.337,95%CI = 1.014 - 1.763,P = 0.040)分析数据时,NQO1基因C609T与前列腺癌风险相关。然而,在白种人中未发现显著关联。这项荟萃分析表明,NQO1基因C609T多态性很可能导致亚洲人患前列腺癌的易感性增加。需要进一步开展大规模、设计良好的病例对照研究,以验证本荟萃分析中确定的风险。

相似文献

1
Association between NQO1 C609T polymorphism and prostate cancer risk.NQO1基因C609T多态性与前列腺癌风险之间的关联。
Tumour Biol. 2014 Aug;35(8):7993-8. doi: 10.1007/s13277-014-2051-5. Epub 2014 May 17.
2
Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.NQO1基因C609T多态性与膀胱癌易感性的关联:一项系统评价和荟萃分析。
Tumour Biol. 2013 Oct;34(5):2551-6. doi: 10.1007/s13277-013-0799-7. Epub 2013 Jun 8.
3
"NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".NQO1基因C609T多态性(dbSNP:rs1800566)与消化道癌风险:一项荟萃分析。
Nutr Cancer. 2018 May-Jun;70(4):557-568. doi: 10.1080/01635581.2018.1460674. Epub 2018 Apr 13.
4
Association between NQO1 C609T polymorphism and colorectal cancer risk.NQO1基因C609T多态性与结直肠癌风险之间的关联。
Tumour Biol. 2013 Dec;34(6):4027-32. doi: 10.1007/s13277-013-0993-7. Epub 2013 Jul 28.
5
A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.NQO1 C609T 变异与急性髓系白血病风险的关联的荟萃分析。
Pediatr Blood Cancer. 2014 May;61(5):771-7. doi: 10.1002/pbc.24924. Epub 2014 Jan 29.
6
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.NAD(P)H:醌氧化还原酶1(NQO1)C609T基因多态性与消化道癌症的关联:一项荟萃分析。
Asian Pac J Cancer Prev. 2013;14(4):2349-54. doi: 10.7314/apjcp.2013.14.4.2349.
7
Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.NQO1 C609T 多态性与急性淋巴细胞白血病风险的关联:基于 17 项病例对照研究的更新荟萃分析证据。
J Cancer Res Clin Oncol. 2014 Jun;140(6):873-81. doi: 10.1007/s00432-014-1595-5. Epub 2014 Feb 2.
8
NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.烟酰胺腺嘌呤二核苷酸(NAD(P)H)醌氧化还原酶 1(NQO1)基因 C609T 多态性与消化道癌风险相关:基于 21 项病例对照研究的荟萃分析。
Eur J Cancer Prev. 2012 Sep;21(5):432-41. doi: 10.1097/CEJ.0b013e32834f7514.
9
Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.NQO1 C609T 多态性对前列腺癌风险的影响:一项荟萃分析。
Onco Targets Ther. 2014 Jun 5;7:907-14. doi: 10.2147/OTT.S62046. eCollection 2014.
10
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H):醌氧化还原酶1(NQO1)C609T基因多态性与肺癌风险的Meta分析
Tumour Biol. 2013 Dec;34(6):3967-79. doi: 10.1007/s13277-013-0985-7. Epub 2013 Jul 14.

引用本文的文献

1
NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associated with prostate tumorigenesis.NQO1 通过抑制 NF-κB-p300 相互作用来调节与前列腺肿瘤发生相关的炎症介质。
Cancer Res. 2014 Oct 1;74(19):5644-55. doi: 10.1158/0008-5472.CAN-14-0562. Epub 2014 Aug 14.

本文引用的文献

1
Expression of RABEX-5 and its clinical significance in prostate cancer.RABEX-5在前列腺癌中的表达及其临床意义
J Exp Clin Cancer Res. 2014 Apr 9;33(1):31. doi: 10.1186/1756-9966-33-31.
2
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer.LAPTM4B-35的过表达:前列腺癌预后不良的一种新标志物。
PLoS One. 2014 Mar 20;9(3):e91069. doi: 10.1371/journal.pone.0091069. eCollection 2014.
3
Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.基于NUCB2蛋白评估的前列腺癌预后预测:前列腺癌中的NUCB2
J Exp Clin Cancer Res. 2013 Oct 16;32(1):77. doi: 10.1186/1756-9966-32-77.
4
High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer.核结合蛋白2信使核糖核酸的高表达:前列腺癌患者总生存的独立预后因素
Tumour Biol. 2014 Mar;35(3):2025-8. doi: 10.1007/s13277-013-1268-z. Epub 2013 Oct 4.
5
Clinical significance of NUCB2 mRNA expression in prostate cancer.前列腺癌中 NUCB2 mRNA 表达的临床意义。
J Exp Clin Cancer Res. 2013 Aug 16;32(1):56. doi: 10.1186/1756-9966-32-56.
6
Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.亚甲基四氢叶酸脱氢酶 1 多态性与癌症的关联:一项荟萃分析。
PLoS One. 2013 Jul 19;8(7):e69366. doi: 10.1371/journal.pone.0069366. Print 2013.
7
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.CYP1B1 多态性与前列腺癌易感性的关系:一项荟萃分析。
PLoS One. 2013 Jul 4;8(7):e68634. doi: 10.1371/journal.pone.0068634. Print 2013.
8
Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk.胰岛素受体底物1 Gly972Arg多态性与癌症风险之间的关联。
Tumour Biol. 2013 Oct;34(5):2929-36. doi: 10.1007/s13277-013-0855-3. Epub 2013 May 25.
9
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.在接受紫杉醇/铂类一线化疗的上皮性卵巢癌患者中,tau 蛋白作为一种潜在的预测标志物。
J Exp Clin Cancer Res. 2013 Apr 30;32(1):25. doi: 10.1186/1756-9966-32-25.
10
Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis.SMAD7 rs12953717 多态性与癌症的关联:一项荟萃分析。
PLoS One. 2013;8(3):e58170. doi: 10.1371/journal.pone.0058170. Epub 2013 Mar 5.